A. Goff

Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach

S. Waddell, K. Fidler, D. Cantillon, 2022, The Lancet. Microbe.

Multi-Omics Technologies Applied to Tuberculosis Drug Discovery

S. Waddell, A. Goff, Dairre Cantillon, 2020, Applied Sciences.

Azetidines kill Mycobacterium tuberculosis without detectable resistance by blocking mycolate assembly

S. Waddell, L. Alderwick, J. Fossey, 2020, bioRxiv.

Dissecting the Mycobacterium bovis BCG Response to Macrophage Infection to Help Prioritize Targets for Anti-Tuberculosis Drug and Vaccine Discovery

P. Bettencourt, S. Waddell, D. Cantillon, 2022, Vaccines.

Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications

S. Waddell, M. Kaforou, A. Gómez-Carballa, 2022, medRxiv.